SCHEMBL12323935

SCHEMBL12323935

COc1ccc(-c2[nH]c(=O)c3ccccc3c2N)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.57
TNKS O95271 3/20 0.52
TNKS2 Q9H2K2 3/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
GUSB P08236 1/20 0.52
CASP3 P42574 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
SERPINE1 P05121 4/20 0.51
PTGS1 P23219 1/20 0.47
KDM4E B2RXH2 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.47
HPGD P15428 1/20 0.47
MAPT P10636 3/20 0.46
KMT2A Q03164 1/20 0.46
PTGS2 P35354 1/20 0.45
CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2431841 0.87 PARP1 (0.49) PARP1TNKSTNKS2NPC1RAB9A
SCHEMBL12323930 0.84 SERPINE1 (0.51) PARP1TNKSTNKS2SERPINE1KDM4E
SCHEMBL29639239 0.83 PTGS2 (0.59) PARP1TNKSTNKS2NPC1RAB9A
SCHEMBL4770018 0.83 PARP1 (0.54) PARP1TNKSTNKS2NPC1RAB9A
SCHEMBL853554 0.83 SERPINE1 (0.72) PARP1TNKSTNKS2NPC1RAB9A
SCHEMBL14867250 0.83 PARP1 (0.54) PARP1TNKSTNKS2NPC1RAB9A
SCHEMBL12323808 0.82 SERPINE1 (0.65) PARP1TNKSTNKS2SERPINE1KDM4E
SCHEMBL14867283 0.80 KDM4E (0.50) PARP1TNKSTNKS2NPC1RAB9A
SCHEMBL12323798 0.77 PARP1 (0.48) PARP1TNKSTNKS2NPC1RAB9A
SCHEMBL854032 0.77 PARP1 (0.62) PARP1TNKSTNKS2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542239-B1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME Université Joseph Fourier (FR) 2015-11-11 EP disclosed
US-8883763-B2 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same UNIVERSITE JOSEPH FOURIER (FR) 2014-11-11 US disclosed
US-8883763-B2 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same UNIVERSITE JOSEPH FOURIER (FR) 2014-11-11 US disclosed
US-20130096083-A1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME UNIVERSITE JOSEPH FOURIER (FR) 2013-04-18 US disclosed
US-20130096083-A1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME UNIVERSITE JOSEPH FOURIER (FR) 2013-04-18 US disclosed
WO-2011107709-A1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME UNIVERSITE JOSEPH FOURIER (FR) 2011-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096083-A1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME GNAQ, HCCS, SDHA PARP1 551/4885TNKS 427/4885TNKS2 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.